When:
Tuesday, April 30, 2024 - 12:00am
We are seeking a partnership with a capable collaborator who can effectively identify natural project actives derived from our proprietary strain. These identified natural products should demonstrate activity against specific pathogens, while not falling under the categories of antibiotics, siderophores, volatile compounds, unstable polyenes, or nonribosomally synthesized peptides. The identification of these natural products can be achieved through metagenomic and bioinformatic approaches, strain engineering, and traditional activity-based fractionation methods.